The 2026-27 Federal Budget and Australia's Clinical Trials Reform Agenda: What International Sponsors Should Know
The 2026-27 Federal Budget confirmed $15.8M to continue the National One Stop Shop, $71M for PrOSPeCT, and $508.5M to step up MRFF disbursements. The Budget also announced material R&D Tax Incentive reforms effective 1 July 2028, including a ten-year refundability age limit and the removal of supporting R&D eligibility. What international clinical trial sponsors should know.
No Exit: What Carr v Ritossa Means for Unit Trust Investors Without a Unitholders' Agreement
When two parties hold property through a jointly held unit trust and the relationship between them breaks down, neither party has a general right to walk away from the arrangement. That position should concern anyone holding property through a unit trust with a co-investor, and anyone advising on such structures. The New South Wales Court of Appeal confirmed the position in David & Ros Carr Holdings Pty Ltd v Ritossa [2025] NSWCA 108, refusing to extend partnership winding-up
